Details for New Drug Application (NDA): 019386
✉ Email this page to a colleague
The generic ingredient in BREVIBLOC IN PLASTIC CONTAINER is esmolol hydrochloride. There are eight drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the esmolol hydrochloride profile page.
Summary for 019386
Tradename: | BREVIBLOC IN PLASTIC CONTAINER |
Applicant: | Baxter Hlthcare |
Ingredient: | esmolol hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 019386
Mechanism of Action | Adrenergic beta-Antagonists |
Suppliers and Packaging for NDA: 019386
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
BREVIBLOC | esmolol hydrochloride | INJECTABLE;INJECTION | 019386 | NDA | Henry Schein, Inc | 0404-9825 | 0404-9825-10 | 1 VIAL, SINGLE-DOSE in 1 BAG (0404-9825-10) / 10 mL in 1 VIAL, SINGLE-DOSE |
BREVIBLOC | esmolol hydrochloride | INJECTABLE;INJECTION | 019386 | NDA | Baxter Healthcare Corporation | 10019-055 | 10019-055-61 | 10 BAG in 1 CARTON (10019-055-61) / 250 mL in 1 BAG |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 10MG/ML | ||||
Approval Date: | Aug 15, 1988 | TE: | RLD: | No |
Profile for product number 004
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 1GM/100ML | ||||
Approval Date: | Feb 16, 2001 | TE: | AP | RLD: | Yes |
Profile for product number 005
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 2GM/100ML | ||||
Approval Date: | Jan 27, 2003 | TE: | AP | RLD: | Yes |
Expired US Patents for NDA 019386
Complete Access Available with Subscription